BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36806188)

  • 41. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
    Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
    Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Expressions of CXCL13, CD10 and bcl-6 in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified].
    Tang XF; Li GD; Li YL; Liang DN; Xia T; Zhou JY; Yao YQ; Wu WQ; Wang ZG; Yang YH; Tang XB; Bai YQ; Ding Q
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):224-30. PubMed ID: 19575892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
    Ghione P; Faruque P; Mehta-Shah N; Seshan V; Ozkaya N; Bhaskar S; Yeung J; Spinner MA; Lunning M; Inghirami G; Moskowitz A; Galasso N; Ganesan N; van der Weyden C; Ruan J; Prince HM; Trotman J; Advani R; Dogan A; Horwitz S
    Blood Adv; 2020 Oct; 4(19):4640-4647. PubMed ID: 33002132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.
    Nakamoto-Matsubara R; Sakata-Yanagimoto M; Enami T; Yoshida K; Yanagimoto S; Shiozawa Y; Nanmoku T; Satomi K; Muto H; Obara N; Kato T; Kurita N; Yokoyama Y; Izutsu K; Ota Y; Sanada M; Shimizu S; Komeno T; Sato Y; Ito T; Kitabayashi I; Takeuchi K; Nakamura N; Ogawa S; Chiba S
    PLoS One; 2014; 9(10):e109714. PubMed ID: 25310466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
    Fujisawa M; Chiba S; Sakata-Yanagimoto M
    J Clin Exp Hematop; 2017; 57(3):109-119. PubMed ID: 29279549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
    Timmins MA; Wagner SD; Ahearne MJ
    Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan.
    Eladl AE; Satou A; Elsayed AA; Suzuki Y; Kato S; Asano N; Nakamura S
    Am J Surg Pathol; 2017 Apr; 41(4):506-516. PubMed ID: 28125450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
    Leca J; Lemonnier F; Meydan C; Foox J; El Ghamrasni S; Mboumba DL; Duncan GS; Fortin J; Sakamoto T; Tobin C; Hodgson K; Haight J; Smith LK; Elia AJ; Butler D; Berger T; de Leval L; Mason CE; Melnick A; Gaulard P; Mak TW
    Cancer Cell; 2023 Feb; 41(2):323-339.e10. PubMed ID: 36736318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angioimmunoblastic T-cell lymphoma-like lymphadenopathy in mice transgenic for human
    Lee GJ; Jun Y; Yoo HY; Jeon YK; Lee D; Lee S; Kim J
    Oncoimmunology; 2020 May; 9(1):1746553. PubMed ID: 32923110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angioimmunoblastic T-cell lymphoma: more than a disease of T follicular helper cells.
    Lemonnier F; Mak TW
    J Pathol; 2017 Aug; 242(4):387-390. PubMed ID: 28543514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics.
    Attygalle AD; Chuang SS; Diss TC; Du MQ; Isaacson PG; Dogan A
    Histopathology; 2007 Mar; 50(4):498-508. PubMed ID: 17448026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop.
    Ondrejka SL; Amador C; Climent F; Ng SB; Soma L; Zamo A; Dirnhofer S; Quintanilla-Martinez L; Wotherspoon A; Leoncini L; de Leval L
    Virchows Arch; 2023 Sep; 483(3):349-365. PubMed ID: 37500795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma].
    Zheng YY; Chen G; Zhou XG; Zhang SH; Zhang YN
    Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):173-7. PubMed ID: 19575853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNMT3A
    Zheng J; Wang Z; Pan X; Zhang Z; Li H; Deng X; Liu P; Zhang Q; Na F; Chen C; Niu T; Liu Y
    Oncogene; 2023 Jun; 42(23):1940-1950. PubMed ID: 37127775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics.
    Botros N; Cerroni L; Shawwa A; Green PJ; Greer W; Pasternak S; Walsh NM
    Am J Dermatopathol; 2015 Apr; 37(4):274-83. PubMed ID: 25794369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neoplasms of follicular helper T-cells: an insight into the pathobiology.
    Jain S; Mallick S; Ramteke P; Gogia A
    Am J Blood Res; 2022; 12(3):64-81. PubMed ID: 35873103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells.
    Dupuis J; Boye K; Martin N; Copie-Bergman C; Plonquet A; Fabiani B; Baglin AC; Haioun C; Delfau-Larue MH; Gaulard P
    Am J Surg Pathol; 2006 Apr; 30(4):490-4. PubMed ID: 16625095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.
    Nicolae A; Pittaluga S; Venkataraman G; Vijnovich-Baron A; Xi L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2013 Jun; 37(6):816-26. PubMed ID: 23598959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.
    Dobay MP; Lemonnier F; Missiaglia E; Bastard C; Vallois D; Jais JP; Scourzic L; Dupuy A; Fataccioli V; Pujals A; Parrens M; Le Bras F; Rousset T; Picquenot JM; Martin N; Haioun C; Delarue R; Bernard OA; Delorenzi M; de Leval L; Gaulard P
    Haematologica; 2017 Apr; 102(4):e148-e151. PubMed ID: 28082343
    [No Abstract]   [Full Text] [Related]  

  • 60. Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.
    Wang M; Zhang S; Chuang SS; Ashton-Key M; Ochoa E; Bolli N; Vassiliou G; Gao Z; Du MQ
    Oncotarget; 2017 Mar; 8(11):17763-17770. PubMed ID: 28148900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.